Lupin’s arm -- Lupin Pharmaceuticals Inc. is recalling 4,554 bottles of Cefixime for Oral Suspension in the US market. The US-based arm of the Mumbai-based drug maker is recalling the affected lot of the drug, used to treat bacterial infections, on account of it being ‘Subpotent’.
Lupin Pharmaceuticals Inc. initiated the Class II recall on August 21. As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1758.10 |
Dr. Reddys Lab | 1320.00 |
Cipla | 1448.00 |
Lupin | 2133.30 |
Zydus Lifesciences | 990.75 |
View more.. |